Rosalie Elespuru, PhD - Testimony
Posted : 01/19/2010     ID ：FDA-2009-N-0519-0009     Agency : FDA

Comment Period Closed
Feb 24,2010 11:59 PM ET

Robert H. Heflich, Division of Genetic and Reproductive Toxicology, U.S. FDA/NCTR - Testimony
Posted : 01/20/2010     ID ：FDA-2009-N-0519-0010     Agency : FDA

Comment Period Closed
Feb 24,2010 11:59 PM ET

Michael C. Cimino, Ph.D. - Comment
Posted : 01/25/2010     ID ：FDA-2009-N-0519-0014     Agency : FDA

Comment Period Closed
Feb 24,2010 11:59 PM ET

Michael C. Cimino, Ph.D. - Comment
Posted : 01/25/2010     ID ：FDA-2009-N-0519-0015     Agency : FDA

Comment Period Closed
Feb 24,2010 11:59 PM ET

Theresa Allio, Ph.D. - FDA/CDER - Comment
Posted : 02/04/2010     ID ：FDA-2009-N-0519-0019     Agency : FDA

Comment Period Closed
Feb 24,2010 11:59 PM ET

Stephane Charbon - Comment
Posted : 02/22/2010     ID ：FDA-2009-N-0519-0021     Agency : FDA

Comment Period Closed
Feb 24,2010 11:59 PM ET

BioReliance Corporation - Comment
Posted : 02/24/2010     ID ：FDA-2009-N-0519-0023     Agency : FDA

Comment Period Closed
Feb 24,2010 11:59 PM ET

U.S. FDA/National Center for Toxicological Research - Testimony
Posted : 03/05/2010     ID ：FDA-2009-N-0519-0025     Agency : FDA

Comment Period Closed
Feb 24,2010 11:59 PM ET